Erythropoietin in Methanol Associated Optic Neuropathy: A Phase-2 Clinical Trial (EPO-MAON Study)

NCT02376881 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Optic Nerve Diseases

Interventions

DRUG: Erythropoietin
OTHER: placebo

Sponsor

Tehran University of Medical Sciences

Collaborators

[object Object]